Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy

Nonalcoholic fatty liver disease (NAFLD) may occur secondarily to several medical conditions. Celiac sprue is the prototypic intestinal condition leading to diverse liver changes, including steatosis/steatohepatitis via increased intestinal permeability [1,2]. Olmersartan has consistently been associated with sprue-like enteropathy [3,4]. Hence, it is tempting to speculate that, similar to what occurs in celiac sprue, liver injury could be a common finding also in olmesartan-induced enteropathy.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2ahZkRV
via IFTTT

FOLFOX4 or sorafenib as the first-line treatments for advanced hepatocellular carcinoma: A cost-effectiveness analysis

This study aimed to investigate the pharmaco-economic implications of FOLFOX4 or sorafenib for advanced hepatocellular carcinoma in China.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2aFh8tD
via IFTTT

Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systemic review and meta-analysis

Cytokine-induced killer cells have been used as an adjuvant treatment for hepatocellular carcinoma with curative treatment. However, the outcomes remain controversial.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2ahZuZi
via IFTTT

Acceptance, yield and feasibility of attaching HCV birth cohort screening to colorectal cancer screening in Spain

The US Centers for Disease Control recommends hepatitis C virus (HCV) screening for baby boomers. Spain presents a similar distribution of infected patients. We performed a cross sectional prospective study to evaluate the prevalence of undiagnosed HCV infection in subjects born between 1949 and 1974.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2aFhOiD
via IFTTT

Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database

Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases associated with a substantial healthcare utilization.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2aSyNdN
via IFTTT

Core Stability in Athletes: A Critical Analysis of Current Guidelines

Abstract

Over the last two decades, exercise of the core muscles has gained major interest in professional sports. Research has focused on injury prevention and increasing athletic performance. We analyzed the guidelines for so-called functional strength training for back pain prevention and found that programs were similar to those for back pain rehabilitation; even the arguments were identical. Surprisingly, most exercise specifications have neither been tested for their effectiveness nor compared with the load specifications normally used for strength training. Analysis of the scientific literature on core stability exercises shows that adaptations in the central nervous system (voluntary activation of trunk muscles) have been used to justify exercise guidelines. Adaptations of morphological structures, important for the stability of the trunk and therefore the athlete's health, have not been adequately addressed in experimental studies or in reviews. In this article, we explain why the guidelines created for back pain rehabilitation are insufficient for strength training in professional athletes. We critically analyze common concepts such as 'selective activation' and training on unstable surfaces.

from Sports Medicine via xlomafota13 on Inoreader http://ift.tt/2amhwed
via IFTTT

Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy

Nonalcoholic fatty liver disease (NAFLD) may occur secondarily to several medical conditions. Celiac sprue is the prototypic intestinal condition leading to diverse liver changes, including steatosis/steatohepatitis via increased intestinal permeability [1,2]. Olmersartan has consistently been associated with sprue-like enteropathy [3,4]. Hence, it is tempting to speculate that, similar to what occurs in celiac sprue, liver injury could be a common finding also in olmesartan-induced enteropathy.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2ahZkRV
via IFTTT

FOLFOX4 or sorafenib as the first-line treatments for advanced hepatocellular carcinoma: A cost-effectiveness analysis

This study aimed to investigate the pharmaco-economic implications of FOLFOX4 or sorafenib for advanced hepatocellular carcinoma in China.

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/2aFh8tD
via IFTTT